Award recordCONTRACT

GENZYME CORPORATION

PIID VA623C80033· VHA· 623-MUSKOGEE· Q301 · LABORATORY TESTING SERVICES· FY2008· $50,945 net obligations· UEI X2XMAQLR9DA8· MA

Description

GENETIC PATIENT TESTING

First action · last action
2007-10-01 · 2007-10-01
Transactions
1
First transaction's obligation
$50,945
Base + all options value (sum of deltas)
$50,945
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$50,945$0Base award · 2007-10-01 · this action $50,945 · running total $50,945
  • Base2007-10-01+$50,945= $50,945
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2007-10-01+$50,945$50,945GENETIC PATIENT TESTING

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26222F0606262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$20,049FY2022

Other recipients under Q301 from 623-MUSKOGEE (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25614J2328BECKMAN COULTER, INC623-MUSKOGEE$525,888FY2014
VA25612J2136LABORATORY CORPORATION OF AMERICA623-MUSKOGEE$70,000FY2012
VA623C10029IRIS INTERNATIONAL, INC.623-MUSKOGEE$4,941FY2011
VA623C10028IRIS INTERNATIONAL, INC.623-MUSKOGEE$9,932FY2011
VA623C10059LABORATORY CORPORATION OF AMERICA623-MUSKOGEE$362,242FY2011

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA623C80033_3600_-NONE-_-NONE- · retrieved 2026-09-26.